Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	high-affinity IgG receptor activity	FCGR1A FCGR1BP	8.26e-05	2	182	2	GO:0019771
GeneOntologyMolecularFunction	leukotriene receptor binding	FCGR1A FCGR1BP	8.26e-05	2	182	2	GO:0031774
GeneOntologyMolecularFunction	dynein intermediate chain binding	DNAH3 DNAH5 DNAH6 HTT	3.49e-04	37	182	4	GO:0045505
GeneOntologyMolecularFunction	ATP-dependent chromatin remodeler activity	EP400 SMARCAL1 INO80 HLTF	3.49e-04	37	182	4	GO:0140658
Domain	-	ISLR2 MXRA5 PRAMEF5 FBXL8 PRAMEF17 LRRC43 TSKU LRFN4 CMIP LRFN2 AMIGO3 PODN XRRA1 PRAMEF6	2.73e-06	321	179	14	3.80.10.10
Domain	L_dom-like	ISLR2 MXRA5 PRAMEF5 FBXL8 PRAMEF17 LRRC43 TSKU LRFN4 CMIP LRFN2 AMIGO3 PODN XRRA1 PRAMEF6	3.51e-06	328	179	14	IPR032675
Domain	LRRNT	ISLR2 MXRA5 TSKU LRFN4 LRFN2 AMIGO3 PODN	4.39e-05	98	179	7	IPR000372
Domain	LRRNT	ISLR2 MXRA5 TSKU LRFN4 LRFN2 AMIGO3 PODN	4.39e-05	98	179	7	SM00013
Domain	-	EPHB6 ISLR2 SDK2 MXRA5 PILRB MXRA8 MR1 CEACAM19 FNDC1 LRFN4 LRFN2 FCGR1A AMIGO3 FCGR1BP PTPRS BTN1A1 EGFLAM KIR3DS1	7.10e-05	663	179	18	2.60.40.10
Domain	Ig-like_dom	ISLR2 SDK2 MXRA5 PILRB MXRA8 MR1 CEACAM19 LRFN4 LRFN2 FCGR1A AMIGO3 FCGR1BP PTPRS BTN1A1 KIR3DS1	1.05e-04	503	179	15	IPR007110
Domain	Ig-like_fold	EPHB6 ISLR2 SDK2 MXRA5 PILRB MXRA8 MR1 CEACAM19 FNDC1 LRFN4 LRFN2 FCGR1A AMIGO3 FCGR1BP PTPRS BTN1A1 EGFLAM KIR3DS1	1.56e-04	706	179	18	IPR013783
Domain	IG	ISLR2 SDK2 MXRA5 PILRB MXRA8 LRFN4 LRFN2 FCGR1A AMIGO3 FCGR1BP PTPRS BTN1A1 KIR3DS1	2.18e-04	421	179	13	SM00409
Domain	Ig_sub	ISLR2 SDK2 MXRA5 PILRB MXRA8 LRFN4 LRFN2 FCGR1A AMIGO3 FCGR1BP PTPRS BTN1A1 KIR3DS1	2.18e-04	421	179	13	IPR003599
Domain	SNF2_N	EP400 SMARCAL1 INO80 HLTF	2.38e-04	32	179	4	IPR000330
Domain	SNF2_N	EP400 SMARCAL1 INO80 HLTF	2.38e-04	32	179	4	PF00176
Domain	LRR_8	ISLR2 MXRA5 LRRC43 TSKU LRFN4 LRFN2 AMIGO3 PODN	2.48e-04	171	179	8	PF13855
Domain	Galactose-bd-like	EPHB6 ALLC LAMA5 F8 NCCRP1 MFGE8	2.89e-04	94	179	6	IPR008979
Domain	Dynein_heavy_chain_D4_dom	DNAH3 DNAH5 DNAH6	2.92e-04	14	179	3	IPR024317
Domain	Dynein_HC_stalk	DNAH3 DNAH5 DNAH6	2.92e-04	14	179	3	IPR024743
Domain	Dynein_heavy_dom-2	DNAH3 DNAH5 DNAH6	2.92e-04	14	179	3	IPR013602
Domain	DHC_N2	DNAH3 DNAH5 DNAH6	2.92e-04	14	179	3	PF08393
Domain	ATPase_dyneun-rel_AAA	DNAH3 DNAH5 DNAH6	2.92e-04	14	179	3	IPR011704
Domain	ATP_GRASP	MCCC1 CARNS1 PCCA	2.92e-04	14	179	3	PS50975
Domain	ATP-grasp	MCCC1 CARNS1 PCCA	2.92e-04	14	179	3	IPR011761
Domain	MT	DNAH3 DNAH5 DNAH6	2.92e-04	14	179	3	PF12777
Domain	AAA_8	DNAH3 DNAH5 DNAH6	2.92e-04	14	179	3	PF12780
Domain	AAA_5	DNAH3 DNAH5 DNAH6	2.92e-04	14	179	3	PF07728
Domain	-	CHST5 DNAH3 PNKP EP400 SMARCAL1 PEX1 RNF213 MCM2 GIMAP1 INO80 AK3 RABL6 ABCB10 SUPV3L1 GPN2 HLTF DNAH5 DNAH6	3.05e-04	746	179	18	3.40.50.300
Domain	LRR_TYP	ISLR2 MXRA5 TSKU LRFN4 LRFN2 AMIGO3 PODN XRRA1	3.13e-04	177	179	8	SM00369
Domain	Leu-rich_rpt_typical-subtyp	ISLR2 MXRA5 TSKU LRFN4 LRFN2 AMIGO3 PODN XRRA1	3.13e-04	177	179	8	IPR003591
Domain	DHC_fam	DNAH3 DNAH5 DNAH6	3.62e-04	15	179	3	IPR026983
Domain	Dynein_heavy	DNAH3 DNAH5 DNAH6	3.62e-04	15	179	3	PF03028
Domain	Dynein_heavy_dom	DNAH3 DNAH5 DNAH6	3.62e-04	15	179	3	IPR004273
Domain	P-loop_NTPase	CHST5 DNAH3 PNKP EP400 SMARCAL1 PEX1 RNF213 MCM2 GIMAP1 INO80 AK3 RABL6 ABCB10 SUPV3L1 GPN2 HLTF DNAH5 DNAH6 KIF22	5.18e-04	848	179	19	IPR027417
Domain	Histone_deAcase_II_euk	HDAC4 HDAC7	5.41e-04	4	179	2	IPR017320
Domain	-	MCCC1 CARNS1 PCCA	6.35e-04	18	179	3	3.30.470.20
Domain	-	EPHB6 ALLC F8 NCCRP1 MFGE8	6.78e-04	73	179	5	2.60.120.260
Domain	PRAME_family	PRAMEF5 PRAMEF17 PRAMEF6	7.49e-04	19	179	3	IPR026271
Domain	Kinase-like_dom	EPHB6 ANKK1 CDK15 CLK4 TEX14 MAPKAPK5 HIPK3 TRIB3 PRKAA1 KNDC1 PKN2 PAN3 MAP4K2 PKN3	7.53e-04	542	179	14	IPR011009
Domain	Prot_kinase_dom	EPHB6 ANKK1 CDK15 CLK4 TEX14 MAPKAPK5 HIPK3 TRIB3 PRKAA1 PKN2 PAN3 MAP4K2 PKN3	8.94e-04	489	179	13	IPR000719
Domain	Biotin_BS	MCCC1 PCCA	8.96e-04	5	179	2	IPR001882
Domain	Biotin_COase_C	MCCC1 PCCA	8.96e-04	5	179	2	IPR005482
Domain	BC	MCCC1 PCCA	8.96e-04	5	179	2	PS50979
Domain	Biotin_carb_C	MCCC1 PCCA	8.96e-04	5	179	2	SM00878
Domain	Biotin_carb_C	MCCC1 PCCA	8.96e-04	5	179	2	PF02785
Domain	Biotin_carboxylation_dom	MCCC1 PCCA	8.96e-04	5	179	2	IPR011764
Domain	-	PKN2 PKN3	8.96e-04	5	179	2	1.10.287.160
Domain	BIOTIN	MCCC1 PCCA	8.96e-04	5	179	2	PS00188
Domain	IG_LIKE	ISLR2 SDK2 MXRA5 PILRB MXRA8 MR1 LRFN4 LRFN2 FCGR1A AMIGO3 FCGR1BP PTPRS BTN1A1	9.28e-04	491	179	13	PS50835
Domain	PROTEIN_KINASE_DOM	EPHB6 ANKK1 CDK15 CLK4 TEX14 MAPKAPK5 HIPK3 TRIB3 PRKAA1 PKN2 PAN3 MAP4K2 PKN3	9.63e-04	493	179	13	PS50011
Domain	fn3	EPHB6 SDK2 FNDC1 LRFN4 LRFN2 PTPRS EGFLAM	9.68e-04	162	179	7	PF00041
Domain	Leu-rich_rpt	ISLR2 MXRA5 LRRC43 TSKU LRFN4 LRFN2 AMIGO3 PODN XRRA1	1.24e-03	271	179	9	IPR001611
Domain	Rudment_hybrid_motif	MCCC1 PCCA	1.34e-03	6	179	2	IPR011054
Domain	CPSASE_2	MCCC1 PCCA	1.34e-03	6	179	2	PS00867
Domain	Hr1	PKN2 PKN3	1.86e-03	7	179	2	SM00742
Domain	CbamoylP_synth_lsu-like_ATP-bd	MCCC1 PCCA	1.86e-03	7	179	2	IPR005479
Domain	BC-like_N	MCCC1 PCCA	1.86e-03	7	179	2	IPR005481
Domain	CPSase_L_D2	MCCC1 PCCA	1.86e-03	7	179	2	PF02786
Domain	Biotin_carb_N	MCCC1 PCCA	1.86e-03	7	179	2	PF00289
Domain	IGc2	SDK2 MXRA5 LRFN4 LRFN2 FCGR1A AMIGO3 FCGR1BP PTPRS	1.97e-03	235	179	8	SM00408
Domain	Ig_sub2	SDK2 MXRA5 LRFN4 LRFN2 FCGR1A AMIGO3 FCGR1BP PTPRS	1.97e-03	235	179	8	IPR003598
Domain	FN3	EPHB6 SDK2 FNDC1 LRFN4 LRFN2 PTPRS EGFLAM	2.08e-03	185	179	7	SM00060
Domain	HR1	PKN2 PKN3	2.46e-03	8	179	2	PF02185
Domain	S_TKc	ANKK1 CDK15 CLK4 MAPKAPK5 HIPK3 TRIB3 PRKAA1 PKN2 MAP4K2 PKN3	2.49e-03	359	179	10	SM00220
Domain	AAA	DNAH3 PEX1 RNF213 ABCB10 DNAH5 DNAH6	2.67e-03	144	179	6	SM00382
Domain	AAA+_ATPase	DNAH3 PEX1 RNF213 ABCB10 DNAH5 DNAH6	2.67e-03	144	179	6	IPR003593
Pathway	REACTOME_CELL_JUNCTION_ORGANIZATION	SDK2 PARVB CDH24 ADAM33 CTNND1 CDH15	6.12e-05	73	132	6	MM15126
Pathway	REACTOME_CELL_CELL_JUNCTION_ORGANIZATION	SDK2 CDH24 ADAM33 CTNND1 CDH15	8.27e-05	48	132	5	MM15069
Pathway	REACTOME_REGULATION_OF_CDH11_FUNCTION	CDH24 ADAM33 CTNND1	1.25e-04	11	132	3	M48015
Pathway	KEGG_MEDICUS_REFERENCE_NUCLEAR_EXPORT_OF_MRNA	NUP88 NUP205 NUP210 NUP188	1.67e-04	30	132	4	M47752
Pathway	REACTOME_REGULATION_OF_GLUCOKINASE_BY_GLUCOKINASE_REGULATORY_PROTEIN	NUP88 NUP205 NUP210 NUP188	2.16e-04	32	132	4	M29579
Pathway	REACTOME_EXPORT_OF_VIRAL_RIBONUCLEOPROTEINS_FROM_NUCLEUS	NUP88 NUP205 NUP210 NUP188	2.43e-04	33	132	4	M27016
Pathway	REACTOME_NUCLEAR_IMPORT_OF_REV_PROTEIN	NUP88 NUP205 NUP210 NUP188	2.74e-04	34	132	4	M27041
Pathway	REACTOME_CELL_CELL_COMMUNICATION	SDK2 PARVB CDH24 ADAM33 CTNND1 CDH15	2.80e-04	96	132	6	MM14592
Pathway	REACTOME_SUMOYLATION_OF_SUMOYLATION_PROTEINS	NUP88 NUP205 NUP210 NUP188	3.07e-04	35	132	4	M27320
Pathway	REACTOME_TRANSPORT_OF_THE_SLBP_DEPENDANT_MATURE_MRNA	NUP88 NUP205 NUP210 NUP188	3.43e-04	36	132	4	M26974
Pathway	REACTOME_NUCLEAR_PORE_COMPLEX_NPC_DISASSEMBLY	NUP88 NUP205 NUP210 NUP188	3.43e-04	36	132	4	M27245
Pathway	REACTOME_SUMOYLATION_OF_CHROMATIN_ORGANIZATION_PROTEINS	HDAC4 NUP88 NUP205 NUP210 NUP188	3.51e-04	65	132	5	MM15147
Pathway	REACTOME_INTERACTIONS_OF_VPR_WITH_HOST_CELLULAR_PROTEINS	NUP88 NUP205 NUP210 NUP188	3.82e-04	37	132	4	M1029
Pathway	REACTOME_INTERACTIONS_OF_REV_WITH_HOST_CELLULAR_PROTEINS	NUP88 NUP205 NUP210 NUP188	3.82e-04	37	132	4	M27038
Pathway	REACTOME_SUMOYLATION_OF_UBIQUITINYLATION_PROTEINS	NUP88 NUP205 NUP210 NUP188	4.69e-04	39	132	4	M27238
Pathway	REACTOME_ADHERENS_JUNCTIONS_INTERACTIONS	CDH24 ADAM33 CTNND1 CDH15	5.17e-04	40	132	4	MM15060
Pathway	REACTOME_NUCLEAR_PORE_COMPLEX_NPC_DISASSEMBLY	NUP88 NUP205 NUP210 NUP188	5.17e-04	40	132	4	MM14945
Pathway	REACTOME_SUMOYLATION_OF_CHROMATIN_ORGANIZATION_PROTEINS	HDAC4 NUP88 NUP205 NUP210 NUP188	5.30e-04	71	132	5	M27394
Pathway	REACTOME_NS1_MEDIATED_EFFECTS_ON_HOST_PATHWAYS	NUP88 NUP205 NUP210 NUP188	5.69e-04	41	132	4	M29574
Pathway	REACTOME_TRANSCRIPTIONAL_REGULATION_BY_SMALL_RNAS	NUP88 NUP205 NUP210 NUP188	5.69e-04	41	132	4	MM15200
Pathway	REACTOME_SUMOYLATION_OF_SUMOYLATION_PROTEINS	NUP88 NUP205 NUP210 NUP188	6.24e-04	42	132	4	MM15039
Pathway	REACTOME_TRANSPORT_OF_THE_SLBP_DEPENDANT_MATURE_MRNA	NUP88 NUP205 NUP210 NUP188	6.83e-04	43	132	4	MM14609
Pathway	REACTOME_TRANSPORT_OF_MATURE_MRNAS_DERIVED_FROM_INTRONLESS_TRANSCRIPTS	NUP88 NUP205 NUP210 NUP188	6.83e-04	43	132	4	M26975
Pathway	REACTOME_VIRAL_MESSENGER_RNA_SYNTHESIS	NUP88 NUP205 NUP210 NUP188	7.46e-04	44	132	4	M109
Pathway	REACTOME_SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS	NUP88 HDAC7 NUP205 NUP210 NUP188	7.69e-04	77	132	5	M27226
Pathway	REACTOME_CELL_JUNCTION_ORGANIZATION	SDK2 PARVB CDH24 ADAM33 CTNND1 CDH15	8.05e-04	117	132	6	M19248
Pathway	KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_RETROGRADE_AXONAL_TRANSPORT	DNAH3 DNAH5 DNAH6 HTT	8.13e-04	45	132	4	M47670
Pathway	REACTOME_SYNAPTIC_ADHESION_LIKE_MOLECULES	LRFN4 LRFN2 PTPRS	8.14e-04	20	132	3	MM15485
Pathway	REACTOME_SUMOYLATION_OF_DNA_REPLICATION_PROTEINS	NUP88 NUP205 NUP210 NUP188	8.84e-04	46	132	4	M27397
Pathway	REACTOME_SYNAPTIC_ADHESION_LIKE_MOLECULES	LRFN4 LRFN2 PTPRS	9.43e-04	21	132	3	M27736
Pathway	REACTOME_SUMOYLATION_OF_RNA_BINDING_PROTEINS	NUP88 NUP205 NUP210 NUP188	9.59e-04	47	132	4	M27395
Pathway	REACTOME_SUMOYLATION_OF_UBIQUITINYLATION_PROTEINS	NUP88 NUP205 NUP210 NUP188	9.59e-04	47	132	4	MM14939
Pathway	REACTOME_GENE_SILENCING_BY_RNA	NUP88 NUP205 NUP210 NUP188	1.12e-03	49	132	4	MM14837
Pathway	REACTOME_SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS	NUP88 HDAC7 NUP205 NUP210 NUP188	1.14e-03	84	132	5	MM14929
Pathway	REACTOME_TRANSPORT_OF_MATURE_MRNAS_DERIVED_FROM_INTRONLESS_TRANSCRIPTS	NUP88 NUP205 NUP210 NUP188	1.21e-03	50	132	4	MM14610
Pathway	REACTOME_VITAMINS	CYP27B1 CYP26C1	1.27e-03	6	132	2	M27125
Pathway	REACTOME_VITAMINS	CYP27B1 CYP26C1	1.27e-03	6	132	2	MM14840
Pathway	REACTOME_SUMOYLATION_OF_DNA_REPLICATION_PROTEINS	NUP88 NUP205 NUP210 NUP188	1.31e-03	51	132	4	MM15151
Pathway	REACTOME_NUCLEAR_ENVELOPE_BREAKDOWN	NUP88 NUP205 NUP210 NUP188	1.51e-03	53	132	4	M27212
Pathway	REACTOME_CELL_CELL_JUNCTION_ORGANIZATION	SDK2 CDH24 ADAM33 CTNND1 CDH15	1.55e-03	90	132	5	M820
Pathway	WP_THYROXINE_THYROID_HORMONE_PRODUCTION	TPO PRKAA1 SLC26A6	1.59e-03	25	132	3	M39353
Pathway	REACTOME_SNRNP_ASSEMBLY	NUP88 NUP205 NUP210 NUP188	1.62e-03	54	132	4	M29594
Pathway	REACTOME_NUCLEAR_ENVELOPE_BREAKDOWN	NUP88 NUP205 NUP210 NUP188	1.73e-03	55	132	4	MM14917
Pathway	REACTOME_CDH11_HOMOTYPIC_AND_HETEROTYPIC_INTERACTIONS	CDH24 CTNND1	1.77e-03	7	132	2	M48038
Pathway	KEGG_MEDICUS_REFERENCE_LEUCINE_DEGRADATION	ACADM MCCC1	1.77e-03	7	132	2	M47633
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	ARHGEF19 EP400 CTC1 LAMA5 PARVB INO80 IDUA MAPKAPK5 PLEKHG5 HDAC7 RABL6 TMEM129 URB1 PSME4 TRIB3 PTPRS PAXIP1 NINL OGDHL NUP188 FEM1A RGL2 CEP170B PKN3 ARHGAP33 HTT	1.86e-10	1105	183	26	35748872
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	ISLR2 SDK2 EP400 LAMA5 MCM2 INO80 PLEKHG5 NUP205 PSME4 AMIGO3 ARHGAP31 NINL NUP188 CARNS1 ANKS1A	1.57e-07	529	183	15	14621295
Pubmed	Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.	PRAMEF5 CTC1 CYP27B1 PEX1 PRAMEF17 INO80 DUS3L NCDN RPRD1B URB1 PSME4 PPP6C PRKAA1 TRAPPC10 OGDHL CEP295 NUP188 PAN3 PRAMEF6	5.03e-06	1084	183	19	11544199
Pubmed	The secreted protein discovery initiative (SPDI), a large-scale effort to identify novel human secreted and transmembrane proteins: a bioinformatics assessment.	RMND5B CHST5 TCTN3 ISLR2 PRADC1 MXRA8 ADAM12 DIPK2B TSKU CEACAM19 HHIP CDH24 AMIGO3 LRP10 GPN2 PODN ADAM33 PAN3	5.13e-06	985	183	18	12975309
Pubmed	Human CCAAT/enhancer-binding protein β interacts with chromatin remodeling complexes of the imitation switch subfamily.	PNKP SMARCAL1 INO80 PAXIP1 HLTF	5.44e-06	48	183	5	22242598
Pubmed	Oogenesis specific genes (Nobox, Oct4, Bmp15, Gdf9, Oogenesin1 and Oogenesin2) are differentially expressed during natural and gonadotropin-induced mouse follicular development.	PRAMEF5 PRAMEF17 GDF9 PRAMEF6	6.07e-06	23	183	4	19480014
Pubmed	HSF1 phosphorylation establishes an active chromatin state via the TRRAP-TIP60 complex and promotes tumorigenesis.	IRF2BP1 EP400 NUP88 PEX1 LAMA5 EMILIN1 NUP205 ESYT3 LRFN4 FCGR1BP NUP210 HLTF OSTF1 VSIG10L2 ANKS1A	1.22e-05	754	183	15	35906200
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	HDAC4 MYRIP RNF213 PARVB NCDN SHKBP1 HIPK3 PARP10 CMIP LRFN2 GTF3C1 PTPRS NUP210 KNDC1 OSTF1 CTNND1 PAN3 PCCA CEP170B CDH15 HTT ANKS1A	1.31e-05	1489	183	22	28611215
Pubmed	Progesterone induced Warburg effect in HEK293 cells is associated with post-translational modifications and proteasomal degradation of progesterone receptor membrane component 1.	PNKP HDAC4 PPP6C PTPRS KNDC1	1.40e-05	58	183	5	31067491
Pubmed	An abundance of X-linked genes expressed in spermatogonia.	PRAMEF5 STRA8 PRAMEF17 TEX14 PRAMEF6	1.52e-05	59	183	5	11279525
Pubmed	TTF-1/NKX2-1 binds to DDB1 and confers replication stress resistance to lung adenocarcinomas.	PNKP IRF2BP1 NUP88 MCM2 NUP205 NUP210 NUP188	1.69e-05	152	183	7	28192407
Pubmed	Deterministic and stochastic allele specific gene expression in single mouse blastomeres.	PRAMEF5 HDAC4 ACADM STRA8 ESRRB PRAMEF17 GDF9 TERT HDAC7 PRAMEF6 DNMT3A	1.70e-05	424	183	11	21731673
Pubmed	Integrated structural analysis of the human nuclear pore complex scaffold.	NUP88 NUP205 NUP210 NUP188	1.83e-05	30	183	4	24315095
Pubmed	The Structure Inventory of the Nuclear Pore Complex.	NUP88 NUP205 NUP210 NUP188	1.83e-05	30	183	4	27016207
Pubmed	Thirteen Ovary-Enriched Genes Are Individually Not Essential for Female Fertility in Mice.	PRAMEF5 PRAMEF17 PKD1L2 PRAMEF6	1.83e-05	30	183	4	38786026
Pubmed	Single Nucleotide Polymorphisms of the High Affinity IgG Receptor FcγRI Reduce Immune Complex Binding and Downstream Effector Functions.	FCGR1A FCGR1BP	2.75e-05	2	183	2	28814603
Pubmed	Features and protective efficacy of human mAbs targeting Mycobacterium tuberculosis arabinomannan.	FCGR1A FCGR1BP	2.75e-05	2	183	2	37733444
Pubmed	A SIRT3/AMPK/autophagy network orchestrates the protective effects of trans-resveratrol in stressed peritoneal macrophages and RAW 264.7 macrophages.	SIRT3 PRKAA1	2.75e-05	2	183	2	27021965
Pubmed	Congenic mapping of the insulin-dependent diabetes (Idd) gene, Idd10, localizes two genes mediating the Idd10 effect and eliminates the candidate Fcgr1.	FCGR1A FCGR1BP	2.75e-05	2	183	2	9257847
Pubmed	The interaction of N-glycans in Fcγ receptor I α-chain with Escherichia coli K1 outer membrane protein A for entry into macrophages: experimental and computational analysis.	FCGR1A FCGR1BP	2.75e-05	2	183	2	25231998
Pubmed	Lentivirus-mediated knockdown of FcγRI (CD64) attenuated lupus nephritis via inhibition of NF-κB regulating NLRP3 inflammasome activation in MRL/lpr mice.	FCGR1A FCGR1BP	2.75e-05	2	183	2	30190171
Pubmed	ADAM33 and ADAM12 genetic polymorphisms and their expression in Egyptian children with asthma.	ADAM12 ADAM33	2.75e-05	2	183	2	26553447
Pubmed	Molecular cloning and expression of the mouse high affinity Fc receptor for IgG.	FCGR1A FCGR1BP	2.75e-05	2	183	2	2136886
Pubmed	FcRγ deficiency improves survival in experimental sepsis by down-regulating TLR4 signaling pathway.	FCGR1A FCGR1BP	2.75e-05	2	183	2	30552619
Pubmed	Sensory Neuron Expressed FcγRI Mediates Postinflammatory Arthritis Pain in Female Mice.	FCGR1A FCGR1BP	2.75e-05	2	183	2	35833115
Pubmed	Bi-Allelic Mutations in NUP205 and NUP210 Are Associated With Abnormal Cardiac Left-Right Patterning.	NUP205 NUP210	2.75e-05	2	183	2	31306055
Pubmed	Differential gene expression modulated by the cytoplasmic domain of Fc gamma RIa (CD64) alpha-chain.	FCGR1A FCGR1BP	2.75e-05	2	183	2	15528358
Pubmed	Fc receptors and the common gamma-chain in experimental autoimmune encephalomyelitis.	FCGR1A FCGR1BP	2.75e-05	2	183	2	14991835
Pubmed	Definition of interferon gamma-response elements in a novel human Fc gamma receptor gene (Fc gamma RIb) and characterization of the gene structure.	FCGR1A FCGR1BP	2.75e-05	2	183	2	1402657
Pubmed	Mouse FcgammaRI: identification and functional characterization of five new alleles.	FCGR1A FCGR1BP	2.75e-05	2	183	2	10752630
Pubmed	Neuronal FcγRI mediates acute and chronic joint pain.	FCGR1A FCGR1BP	2.75e-05	2	183	2	31211699
Pubmed	Inhibition of HIPK3 by AST487 Ameliorates Mutant HTT-Induced Neurotoxicity and Apoptosis via Enhanced Autophagy.	HIPK3 HTT	2.75e-05	2	183	2	34741261
Pubmed	Reconstitution of allogeneic hemopoietic stem cells: the essential role of FcR gamma and the TCR beta-chain-FCp33 complex.	FCGR1A FCGR1BP	2.75e-05	2	183	2	16849450
Pubmed	Mutant huntingtin inhibits the mitochondrial unfolded protein response by impairing ABCB10 mRNA stability.	ABCB10 HTT	2.75e-05	2	183	2	30802639
Pubmed	CD64 plays a key role in diabetic wound healing.	FCGR1A FCGR1BP	2.75e-05	2	183	2	38524127
Pubmed	Developmentally ordered appearance of a functional Fc gamma receptor on TCR V gamma 3 thymocytes. Evidence for stimulation-induced expression.	FCGR1A FCGR1BP	2.75e-05	2	183	2	8077658
Pubmed	HDAC4 reduction: a novel therapeutic strategy to target cytoplasmic huntingtin and ameliorate neurodegeneration.	HDAC4 HTT	2.75e-05	2	183	2	24302884
Pubmed	Class IIa HDAC4 and HDAC7 cooperatively regulate gene transcription in Th17 cell differentiation.	HDAC4 HDAC7	2.75e-05	2	183	2	38657041
Pubmed	Modulating IgG effector function by Fc glycan engineering.	FCGR1A FCGR1BP	2.75e-05	2	183	2	28289219
Pubmed	Amelioration of Lupus Serum-Induced Skin Inflammation in CD64-Deficient Mice.	FCGR1A FCGR1BP	2.75e-05	2	183	2	35273604
Pubmed	IgG3-mediated enhancement of the antibody response is normal in Fc gammaRI-deficient mice.	FCGR1A FCGR1BP	2.75e-05	2	183	2	16305642
Pubmed	Fcγ receptor I alpha chain (CD64) expression in macrophages is critical for the onset of meningitis by Escherichia coli K1.	FCGR1A FCGR1BP	2.75e-05	2	183	2	21124939
Pubmed	Macrophages eliminate circulating tumor cells after monoclonal antibody therapy.	FCGR1A FCGR1BP	2.75e-05	2	183	2	24430180
Pubmed	Expression of modified FcγRI enables myeloid cells to elicit robust tumor-specific cytotoxicity.	FCGR1A FCGR1BP	2.75e-05	2	183	2	38885133
Pubmed	Novel Fc gamma receptor I family gene products in human mononuclear cells.	FCGR1A FCGR1BP	2.75e-05	2	183	2	1430234
Pubmed	The FcRgamma chain is not essential for induction of experimental allergic encephalomyelitis (EAE) or anti-myelin antibody-mediated exacerbation of EAE.	FCGR1A FCGR1BP	2.75e-05	2	183	2	15835266
Pubmed	Extracellular mutations of non-obese diabetic mouse FcgammaRI modify surface expression and ligand binding.	FCGR1A FCGR1BP	2.75e-05	2	183	2	8663283
Pubmed	Gene organization of the human high affinity receptor for IgG, Fc gamma RI (CD64). Characterization and evidence for a second gene.	FCGR1A FCGR1BP	2.75e-05	2	183	2	1830050
Pubmed	AMPK-α1 functions downstream of oxidative stress to mediate neuronal atrophy in Huntington's disease.	PRKAA1 HTT	2.75e-05	2	183	2	24946181
Pubmed	AMP-activated protein kinase regulates the expression of human telomerase reverse transcriptase.	TERT PRKAA1	2.75e-05	2	183	2	30475873
Pubmed	Functional characteristics of the high affinity IgG receptor, FcγRI.	FCGR1A FCGR1BP	2.75e-05	2	183	2	21325219
Pubmed	FcR gamma-chain is essential for both surface expression and function of human Fc gamma RI (CD64) in vivo.	FCGR1A FCGR1BP	2.75e-05	2	183	2	8611682
Pubmed	Direct targeting of genetically modified tumour cells to Fc gammaRI triggers potent tumour cytotoxicity.	FCGR1A FCGR1BP	2.75e-05	2	183	2	16409296
Pubmed	Fcγ Receptor Type I (CD64)-Mediated Impairment of the Capacity of Dendritic Cells to Activate Specific CD8 T Cells by IgG-opsonized Friend Virus.	FCGR1A FCGR1BP	2.75e-05	2	183	2	30744065
Pubmed	Serum anti-Fcgamma receptor autoantibodies in patients with alopecia areata.	FCGR1A FCGR1BP	2.75e-05	2	183	2	17124586
Pubmed	Linkage on chromosome 3 of autoimmune diabetes and defective Fc receptor for IgG in NOD mice.	FCGR1A FCGR1BP	2.75e-05	2	183	2	8480181
Pubmed	Fc Effector Function Contributes to the Activity of Human Anti-CTLA-4 Antibodies.	FCGR1A FCGR1BP	2.75e-05	2	183	2	29576375
Pubmed	Amelioration of crescentic glomerulonephritis by RhoA kinase inhibitor, Fasudil, through podocyte protection and prevention of leukocyte migration.	FCGR1A FCGR1BP	2.75e-05	2	183	2	18245810
Pubmed	Biochemical characterization of murine Fc gamma RI.	FCGR1A FCGR1BP	2.75e-05	2	183	2	8478020
Pubmed	FcγR-binding affinity of monoclonal murine IgG1s carrying different N-linked Fc oligosaccharides.	FCGR1A FCGR1BP	2.75e-05	2	183	2	31554601
Pubmed	The Proteasome Activators Blm10/PA200 Enhance the Proteasomal Degradation of N-Terminal Huntingtin.	PSME4 HTT	2.75e-05	2	183	2	33233776
Pubmed	The involvement of FcR mechanisms in antibody-mediated rejection.	FCGR1A FCGR1BP	2.75e-05	2	183	2	18049118
Pubmed	Expression pattern of LRR and Ig domain-containing protein (LRRIG protein) in the early mouse embryo.	ISLR2 LRFN4 LRFN2 AMIGO3	3.04e-05	34	183	4	18848646
Pubmed	Identification of dynein heavy chain genes expressed in human and mouse testis: chromosomal localization of an axonemal dynein gene.	DNAH3 DNAH5 DNAH6	5.00e-05	14	183	3	9373155
Pubmed	Phase-separated nuclear bodies of nucleoporin fusions promote condensation of MLL1/CRM1 and rearrangement of 3D genome structure.	NUP88 NUP205 NUP210 NUP188	5.85e-05	40	183	4	37516964
Pubmed	High-throughput RNAi screening reveals novel regulators of telomerase.	PNKP MAPKAPK5 TERT	7.63e-05	16	183	3	21531765
Pubmed	Neonatal Fc receptor for IgG regulates mucosal immune responses to luminal bacteria.	FCGR1A FCGR1BP	8.23e-05	3	183	2	16841095
Pubmed	Regulation of pre-fusion events: recruitment of M-cadherin to microrafts organized at fusion-competent sites of myogenic cells.	CTNND1 CDH15	8.23e-05	3	183	2	23978243
Pubmed	MEK kinase 2 and the adaptor protein Lad regulate extracellular signal-regulated kinase 5 activation by epidermal growth factor via Src.	SH2D2A PKN2	8.23e-05	3	183	2	12640115
Pubmed	Blocking the association of HDAC4 with MAP1S accelerates autophagy clearance of mutant Huntingtin.	HDAC4 HTT	8.23e-05	3	183	2	26540094
Pubmed	Serine phosphorylation of FcγRI cytoplasmic domain directs lipid raft localization and interaction with protein 4.1G.	FCGR1A FCGR1BP	8.23e-05	3	183	2	22003208
Pubmed	Time for remodeling: SNF2-family DNA translocases in replication fork metabolism and human disease.	SMARCAL1 HLTF	8.23e-05	3	183	2	32971328
Pubmed	Suppression of MAPK11 or HIPK3 reduces mutant Huntingtin levels in Huntington's disease models.	HIPK3 HTT	8.23e-05	3	183	2	29151587
Pubmed	Identification of a signal-responsive nuclear export sequence in class II histone deacetylases.	HDAC4 HDAC7	8.23e-05	3	183	2	11509672
Pubmed	Unique monoclonal antibodies define expression of Fc gamma RI on macrophages and mast cell lines and demonstrate heterogeneity among subcutaneous and other dendritic cells.	FCGR1A FCGR1BP	8.23e-05	3	183	2	12594281
Pubmed	Development of proteoglycan-induced arthritis is critically dependent on Fcgamma receptor type III expression.	FCGR1A FCGR1BP	8.23e-05	3	183	2	15880819
Pubmed	A new mouse expressing human Fcγ receptors to better predict therapeutic efficacy of human anti-cancer antibodies.	FCGR1A FCGR1BP	8.23e-05	3	183	2	28924242
Pubmed	FcγRI mediates serum amyloid P inhibition of fibrocyte differentiation.	FCGR1A FCGR1BP	8.23e-05	3	183	2	22493081
Pubmed	Escherichia coli K1 induces pterin production for enhanced expression of Fcγ receptor I to invade RAW 264.7 macrophages.	FCGR1A FCGR1BP	8.23e-05	3	183	2	24161960
Pubmed	Functions of SMARCAL1, ZRANB3, and HLTF in maintaining genome stability.	SMARCAL1 HLTF	8.23e-05	3	183	2	28954549
Pubmed	FcgammaRI ligation leads to a complex with BLT1 in lipid rafts that enhances rat lung macrophage antimicrobial functions.	FCGR1A FCGR1BP	8.23e-05	3	183	2	19657115
Pubmed	DNAH6 and Its Interactions with PCD Genes in Heterotaxy and Primary Ciliary Dyskinesia.	DNAH5 DNAH6	8.23e-05	3	183	2	26918822
Pubmed	Inhibition of DNA Methyltransferases Blocks Mutant Huntingtin-Induced Neurotoxicity.	HTT DNMT3A	8.23e-05	3	183	2	27516062
Pubmed	Nuclear translocation of AMPK-alpha1 potentiates striatal neurodegeneration in Huntington's disease.	PRKAA1 HTT	8.23e-05	3	183	2	21768291
Pubmed	Fc-optimized antibodies elicit CD8 immunity to viral respiratory infection.	FCGR1A FCGR1BP	8.23e-05	3	183	2	33032297
Pubmed	Localization of FCGR1 encoding Fcgamma receptor class I in primates: molecular evidence for two pericentric inversions during the evolution of human chromosome 1.	FCGR1A FCGR1BP	8.23e-05	3	183	2	9763663
Pubmed	Toxicity of an Fc-engineered anti-CD40 antibody is abrogated by intratumoral injection and results in durable antitumor immunity.	FCGR1A FCGR1BP	8.23e-05	3	183	2	30297432
Pubmed	FcgammaRI up-regulation induced by local adenoviral-mediated interferon-gamma production aggravates chondrocyte death during immune complex-mediated arthritis.	FCGR1A FCGR1BP	8.23e-05	3	183	2	12875993
Pubmed	PIAS1 modulates striatal transcription, DNA damage repair, and SUMOylation with relevance to Huntington's disease.	PNKP HTT	8.23e-05	3	183	2	33468657
Pubmed	Nephrotoxic nephritis is mediated by Fcgamma receptors on circulating leukocytes and not intrinsic renal cells.	FCGR1A FCGR1BP	8.23e-05	3	183	2	12427132
Pubmed	MicroRNA-127 inhibits lung inflammation by targeting IgG Fcγ receptor I.	FCGR1A FCGR1BP	8.23e-05	3	183	2	22287715
Pubmed	Tpl2 kinase regulates FcγR signaling and immune thrombocytopenia in mice.	FCGR1A FCGR1BP	8.23e-05	3	183	2	23898046
Pubmed	Cloning genes encoding receptors related to chemoattractant receptors.	GPR32 GPR32P1	8.23e-05	3	183	2	9653656
Pubmed	Placental telomere length decline with gestational age differs by sex and TERT, DNMT1, and DNMT3A DNA methylation.	TERT DNMT3A	8.23e-05	3	183	2	27871469
Pubmed	Fcgamma receptor-mediated induction of dendritic cell maturation and major histocompatibility complex class I-restricted antigen presentation after immune complex internalization.	FCGR1A FCGR1BP	8.23e-05	3	183	2	9892619
Pubmed	Residual LCMV antigen in transiently CD4+ T cell-depleted mice induces high levels of virus-specific antibodies but only limited B-cell memory.	FCGR1A FCGR1BP	8.23e-05	3	183	2	30636035
Pubmed	Cutting Edge: Drebrin-Regulated Actin Dynamics Regulate IgE-Dependent Mast Cell Activation and Allergic Responses.	FCGR1A FCGR1BP	8.23e-05	3	183	2	26056254
Pubmed	The essential role of complement in antibody-mediated resistance to Salmonella.	FCGR1A FCGR1BP	8.23e-05	3	183	2	30179254
Pubmed	The three genes of the human FCGR1 gene family encoding Fc gamma RI flank the centromere of chromosome 1 at 1p12 and 1q21.	FCGR1A FCGR1BP	8.23e-05	3	183	2	8697799
Pubmed	Transcriptional and post-transcriptional regulation of IκB-ζ upon engagement of the BCR, TLRs and FcγR.	FCGR1A FCGR1BP	8.23e-05	3	183	2	23728777
Interaction	ESM1 interactions	FRS3 ADAM12 HDAC7 FAM124B ANKS1A	9.22e-07	21	178	5	int:ESM1
Cytoband	2q36.2	DOCK10 FAM124B	4.73e-05	3	183	2	2q36.2
GeneFamily	Nucleoporins	NUP88 NUP205 NUP210 NUP188	6.53e-05	32	124	4	1051
GeneFamily	Fibronectin type III domain containing	EPHB6 SDK2 FNDC1 LRFN4 LRFN2 PTPRS EGFLAM	1.18e-04	160	124	7	555
GeneFamily	Dyneins, axonemal	DNAH3 DNAH5 DNAH6	2.00e-04	17	124	3	536
GeneFamily	Histone deacetylases, class IIA	HDAC4 HDAC7	2.77e-04	4	124	2	992
GeneFamily	PRAME family	PRAMEF5 PRAMEF17 PRAMEF6	5.74e-04	24	124	3	686
GeneFamily	C2 domain containing protein kinases	PKN2 PKN3	2.03e-03	10	124	2	835
GeneFamily	Immunoglobulin like domain containing	ISLR2 SDK2 MXRA5 FCGR1A AMIGO3 FCGR1BP	2.16e-03	193	124	6	594
ToppCell	-Cryobiopsy_01\|World / lung cells shred on cell class, cell subclass, sample id	MXRA5 CDK15 MXRA8 INPP4B PTPN7 RASAL3 GRAP2 PODN ADAM33	1.16e-07	195	182	9	e5b0afbea85575851cf9eb50a9ac42c67bbf3d7c
ToppCell	LPS-antiTNF-Hematopoietic_Mast-Mast_cells-T-cells\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SH2D2A ADAM12 INPP4B KRT23 PTPN7 RASAL3 SYTL3 GRAP2	1.70e-07	147	182	8	1ecd7c084e73eb6fae1ab1f9aae17115d3d62cbd
ToppCell	Severe-Lymphoid-NK-Proliferating_T\|Severe / Condition, Lineage, Cell class and cell subclass	ACY3 PNLDC1 RASAL3 TRIB3 SUPV3L1 PVRIG PDP2 KIF22	3.25e-07	160	182	8	cb2276d9bd78508644420e9580d3c17b914224cb
ToppCell	356C-Myeloid-Monocyte-CD16+_Monocyte\|Monocyte / Donor, Lineage, Cell class and subclass (all cells)	HAGHL ALKBH2 CYP27B1 NUP88 SH2D2A PNLDC1 ANKDD1A DNMT3A	5.63e-07	172	182	8	9dca1542145d88559527db7e0f6ad150df59ca2d
ToppCell	Immune-mast_cell\|World / Lineage, Cell type, age group and donor	CDK15 ACY3 DOCK10 ADAM12 PTPN7 SYTL3 GRAP2 PDE7B	5.63e-07	172	182	8	6e8e0aac5a20dbc789bf8c6916833bb8709a411a
ToppCell	368C-Endothelial_cells-Endothelial-D\|368C / Donor, Lineage, Cell class and subclass (all cells)	ESRRB LAMA5 F8 DIPK2B CDH24 USHBP1 FAM124B PKN3	6.41e-07	175	182	8	c4088b5f9fa145869cf5dd8bee7680b1c8fada42
ToppCell	368C-Endothelial_cells-Endothelial-D-\|368C / Donor, Lineage, Cell class and subclass (all cells)	ESRRB LAMA5 F8 DIPK2B CDH24 USHBP1 FAM124B PKN3	6.41e-07	175	182	8	ca0d3e3a0a271cccdd3881b055fecb626712478d
ToppCell	facs-Lung-18m-Mesenchymal-myofibroblast-myofibroblast_cell\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	EPHB6 ARHGEF19 PGBD1 TEX14 HHIP NINL MTHFD2L ADAM33	1.02e-06	186	182	8	26458ff8cad5577de4306cffa0ca69eb26940e0d
ToppCell	facs-Lung-18m-Mesenchymal-myofibroblast-myofibroblast_cell-pulmonary_interstitial_myofibroblast\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	EPHB6 ARHGEF19 PGBD1 TEX14 HHIP NINL MTHFD2L ADAM33	1.02e-06	186	182	8	a71397efc68d2916ddc373d92cfd07be58033e1c
ToppCell	5'-Adult-Appendix-Endothelial-blood_vessel_EC-arterial_capillary\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	TPO MYRIP LAMA5 F8 DIPK2B USHBP1 ARHGAP31 RGL2	1.10e-06	188	182	8	a11b12f1857953bcdbfb5f25e127f2350c39567d
ToppCell	facs-Liver-Non-hepatocytes-3m-Lymphocytic\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DOCK10 GIMAP1 SH2D2A ADAM12 INPP4B PTPN7 RASAL3 SYTL3	1.15e-06	189	182	8	039b1922c85aa749d6578583d9d41a4eef8a6ac4
ToppCell	COVID-19-lung-CD4+_T_cells_metabolically_active\|COVID-19 / Disease (COVID-19 only), tissue and cell type	DOCK10 SH2D2A INPP4B PTPN7 RASAL3 SYTL3 NUP210 GRAP2	1.34e-06	193	182	8	326fd2ce2c4b51e5a38f2a7a09f22f8f0e92735a
ToppCell	Adult-Immune-T_lymphocyte\|Adult / Lineage, Cell type, age group and donor	DOCK10 SH2D2A ADAM12 INPP4B PTPN7 RASAL3 SYTL3 GRAP2	1.34e-06	193	182	8	26df0c4c8a2355dd5503fadd07e368eb9a2bf06a
ToppCell	NS-moderate-d_16-33-Lymphoid-CTL\|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	DOCK10 RNF213 GIMAP1 SH2D2A PTPN7 RASAL3 SYTL3 GRAP2	1.39e-06	194	182	8	6b2bb3dd11fd53fa9ab4d66c18b0714f96f99288
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	MXRA8 ADAM12 EMILIN1 HHIP MFGE8 FNDC1 PODN ADAM33	1.39e-06	194	182	8	02b8102be9414d6964cd71019613edff6d88b893
ToppCell	Adult-Immune-T_lymphocyte-D231\|Adult / Lineage, Cell type, age group and donor	DOCK10 SH2D2A ADAM12 INPP4B PTPN7 RASAL3 SYTL3 GRAP2	1.39e-06	194	182	8	5c1dca33f382f37a7deb23e573578343c3b54986
ToppCell	COVID-19-lung-CD4+_T_cells_metabolically_active\|lung / Disease (COVID-19 only), tissue and cell type	DOCK10 SH2D2A INPP4B PTPN7 RASAL3 SYTL3 NUP210 GRAP2	1.39e-06	194	182	8	2a144a1c2d537c8a59aa419206ddd96c23f0aeab
ToppCell	metastatic_Lymph_Node-Fibroblasts\|metastatic_Lymph_Node / Location, Cell class and cell subclass	ISLR2 MXRA5 MXRA8 EMILIN1 MFGE8 FNDC1 PODN EGFLAM	1.50e-06	196	182	8	275e153347caf94edc0c50021bbab49c8696fecb
ToppCell	5'-Adult-Appendix-Endothelial-blood_vessel_EC\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	TPO MYRIP LAMA5 F8 DIPK2B USHBP1 ARHGAP31 PKN3	1.56e-06	197	182	8	e8e879b7634a29569061d3515d180784094a31e7
ToppCell	LPS_only-Epithelial_airway-airway_epithelial-Ciliated\|LPS_only / Treatment groups by lineage, cell group, cell type	TCTN3 DNAH3 HAGHL C21orf58 LRRC43 DNAH5 DNAH6 ARHGAP33	1.62e-06	198	182	8	6d90b541fde357fbb40f8f7d4e8628a48b679718
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Gen_Cap\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	RNF213 PARVB PLEKHG5 HDAC7 DIPK2B USHBP1 CTNND1 FAM124B	1.75e-06	200	182	8	dccec522ab0d7fff62ad6273b02aa9022dbbb8eb
ToppCell	Tracheal-10x3prime_v2-Stromal-Peri/Epineurial_\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	ALLC MXRA8 DUS3L ADAM33 EGFLAM SLC26A6 PSPN DNMT3A	1.75e-06	200	182	8	f7c3a8f5ac156c05ad7335d6d142c154c7d86449
ToppCell	LPS_IL1RA_TNF-Endothelial-Endothelial\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	RNF213 PARVB HDAC7 DIPK2B USHBP1 CTNND1 FAM124B RGL2	1.75e-06	200	182	8	a1fa6bae5a688faf488d6925cd3fad725dfa916b
ToppCell	LPS_IL1RA_TNF-Endothelial\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	RNF213 PARVB HDAC7 DIPK2B USHBP1 CTNND1 FAM124B RGL2	1.75e-06	200	182	8	d01cec331be3b03cef80e9536fc531285bcf00f6
ToppCell	LPS_IL1RA_TNF-Endothelial-Endothelial-Gen_Cap\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	PARVB PLEKHG5 HDAC7 DIPK2B USHBP1 CTNND1 FAM124B RGL2	1.75e-06	200	182	8	b2d4e6f3e8e4da62e6b02758ab2ed8f505269f9a
ToppCell	LPS-IL1RA-Hematopoietic_Mast\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	INPP4B KRT23 PTPN7 RASAL3 SYTL3 GRAP2 PDE7B	1.98e-06	142	182	7	f7d0d5ca9fc3dd929d4fdd59b71bfa623007e992
ToppCell	LPS-IL1RA-Hematopoietic_Mast-Mast_cells\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	INPP4B KRT23 PTPN7 RASAL3 SYTL3 GRAP2 PDE7B	1.98e-06	142	182	7	2a9a070e7c53ac593d46c6c5f6983f07d4413501
ToppCell	LPS-antiTNF-Hematopoietic_Mast-Mast_cells\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ADAM12 INPP4B KRT23 PTPN7 RASAL3 SYTL3 GRAP2	2.73e-06	149	182	7	59aa1f2a5cbeba64c4529fb05f544db17fd8b188
ToppCell	LPS-antiTNF-Hematopoietic_Mast\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ADAM12 INPP4B KRT23 PTPN7 RASAL3 SYTL3 GRAP2	2.73e-06	149	182	7	1527cdd98a2734cbf8ce4c6170557280b71c55cb
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c12-FOXP3\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	HDAC4 DOCK10 SH2D2A ESYT3 PTPN7 RASAL3 MAP4K2	3.70e-06	156	182	7	fbe23876f0899853cea3c5c4f3044a9cea064d5b
ToppCell	droplet-Liver-Hepatocytes-21m-Lymphocytic-NK/T\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GIMAP1 SH2D2A INPP4B PTPN7 RASAL3 SYTL3 GRAP2	4.75e-06	162	182	7	eb2900a250fb3e08e479c727c7d3200cbcf37fbc
ToppCell	droplet-Liver-Hepatocytes-21m-Lymphocytic-NK_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GIMAP1 SH2D2A INPP4B PTPN7 RASAL3 SYTL3 GRAP2	4.75e-06	162	182	7	1ef3084b5766641ec07c6f488c1756239cf3fd61
ToppCell	356C-Myeloid-Monocyte-CD16+_Monocyte\|356C / Donor, Lineage, Cell class and subclass (all cells)	CYP27B1 NUP88 PNLDC1 LRFN4 FCGR1A ANKDD1A DNMT3A	5.35e-06	165	182	7	35a6de30438de364ccca948fc932da541a69ef89
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Granulocytic\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	CDK15 DOCK10 ADAM12 PTPN7 GRAP2 SCNN1D CARNS1	6.51e-06	170	182	7	be2a34c70665d8d11332b1a70eda03d77cb7f7dd
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Granulocytic\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CDK15 DOCK10 PARVB SH2D2A ADAM12 PTPN7 GRAP2	7.03e-06	172	182	7	3a37569a5902f3c65ff8d3912421309a8c82ee9b
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Granulocytic-Mast_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CDK15 DOCK10 PARVB SH2D2A ADAM12 PTPN7 GRAP2	7.03e-06	172	182	7	cc9d9dae290f11f8c348c78228af4e49469dc93b
ToppCell	droplet-Lung-nan-18m-Lymphocytic-Natural_Killer_T_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GIMAP1 SH2D2A INPP4B PTPN7 RASAL3 SYTL3 GRAP2	7.58e-06	174	182	7	5b00a795a9dd1a77305fcac5017cb276afdc1a27
ToppCell	droplet-Lung-nan-18m-Lymphocytic-mature_NK_T_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GIMAP1 SH2D2A INPP4B PTPN7 RASAL3 SYTL3 GRAP2	7.58e-06	174	182	7	3340b44c77f55244e3c2e2ea479d42563f937040
ToppCell	Healthy_Control-Myeloid-Mast\|Healthy_Control / Condition, Lineage, Cell class and cell subclass	CDK15 MYRIP ADAM12 HHIP PTPN7 GRAP2 CARNS1	7.87e-06	175	182	7	ca187074adcc9b8bd0fa270e2ede1564c8e6c6cf
ToppCell	Healthy_Control-Myeloid-Mast-\|Healthy_Control / Condition, Lineage, Cell class and cell subclass	CDK15 MYRIP ADAM12 HHIP PTPN7 GRAP2 CARNS1	7.87e-06	175	182	7	eadbbcdf2aef4cee268bc70a7a2c4175d898953b
ToppCell	LPS-IL1RA+antiTNF-Lymphocytic_NKT\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DOCK10 INPP4B PTPN7 RASAL3 SYTL3 GRAP2 PVRIG	8.48e-06	177	182	7	f1efd9c3074d5635700fe7fbebf3dd0b1e0a84f1
ToppCell	3'-GW_trimst-1-SmallIntestine-Hematopoietic-T_cells-ILC2\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FBXL8 GIMAP1 SH2D2A LRRC43 PTPN7 GRAP2 OSTF1	8.48e-06	177	182	7	9828504591599619649d41a78daf7c052729c669
ToppCell	droplet-Lung-18m-Hematologic-lymphocytic-mature_NK_T_cell\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	GIMAP1 SH2D2A INPP4B PTPN7 RASAL3 SYTL3 GRAP2	8.80e-06	178	182	7	28bb1e3e447261d0cb47e2b6343b17b2d74db525
ToppCell	droplet-Tongue-nan-24m-Myeloid-nan\|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GIMAP1 SH2D2A PTPN7 RASAL3 SYTL3 GRAP2 FAM124B	9.12e-06	179	182	7	1b079d80f789473701c781f3431ad306e9766797
ToppCell	droplet-Lung-18m-Hematologic-lymphocytic-mature_NK_T_cell-mature_NK_T_cell_l4\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	GIMAP1 SH2D2A INPP4B PTPN7 RASAL3 SYTL3 GRAP2	9.12e-06	179	182	7	ac0c257e63a5994282d8b350c1b517cc3fbee52a
ToppCell	-Myositis-ILD_01\|World / lung cells shred on cell class, cell subclass, sample id	MXRA5 CDK15 ADAM12 PTPN7 GRAP2 PODN CARNS1	9.81e-06	181	182	7	ef579e958f334da0f9415aa7e3d5c02c807954a6
ToppCell	Control-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DOCK10 KCNB2 HHIP FNDC1 PTPRS PODN ADAM33	1.05e-05	183	182	7	7eae9b3b4d1c9b135fa7cff348393d4adec474b4
ToppCell	droplet-Thymus\|droplet / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EPHB6 GIMAP1 SH2D2A HDAC7 PTPN7 RASAL3 SYTL3	1.13e-05	185	182	7	83a78d17ad59503a694c1250082c4d8ae74d63e1
ToppCell	facs-Lung-EPCAM-18m-Mesenchymal-pulmonary_interstitial_fibroblast\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EPHB6 ARHGEF19 PGBD1 HHIP NINL MTHFD2L ADAM33	1.17e-05	186	182	7	aa88d9573a237b2b8e6025fee31f69fbce824497
ToppCell	facs-Lung-EPCAM-18m-Mesenchymal-Myofibroblast\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EPHB6 ARHGEF19 PGBD1 HHIP NINL MTHFD2L ADAM33	1.17e-05	186	182	7	ecc5acd111a6ee50d59544d1bdd7ed94e2812aae
ToppCell	10x3'2.3-week_17-19-Endothelial-stroma-proliferating_EC\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	TPO MXRA5 DIPK2B ARHGAP31 NINL PDE7B PKN3	1.17e-05	186	182	7	a844d4f79e0ad5d6c60a4488ffd8f4f21b7eed04
ToppCell	droplet-Kidney-nan-18m-Epithelial-Pecam____Kidney_cortex_artery_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ANKK1 ISLR2 MYRIP PARVB KCNB2 FNDC1 PKN3	1.21e-05	187	182	7	e93cad16a087d1443cbf4e1690dc1b35d7a84c41
ToppCell	droplet-Liver-LIVER_NPC-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MXRA8 GIMAP1 ADAM12 HDAC7 F8 MFGE8 USHBP1	1.25e-05	188	182	7	0aa8747c2931b0c91f6d78bb2db8fd8ede6dd559
ToppCell	Globus_pallidus\|World / BrainAtlas - Mouse McCarroll V32	DOCK10 HDAC7 SHKBP1 ESYT3 CHRNA10 RGL2	1.33e-05	126	182	6	44b63f945d5bedf1a2ca1810e7e100276ea9dd89
ToppCell	droplet-Liver-LIVER_NPC-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MXRA8 ADAM12 HDAC7 F8 MFGE8 USHBP1 ARHGAP31	1.34e-05	190	182	7	a08c5929b05a4969852e351a93c4e4deb4c8d5b6
ToppCell	droplet-Liver-LIVER_NPC-30m-Endothelial\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MXRA8 ADAM12 HDAC7 F8 MFGE8 USHBP1 ARHGAP31	1.34e-05	190	182	7	25525fee1da8a808034d9c916159fd0b6b26bce8
ToppCell	facs-Trachea-nan-3m-Lymphocytic\|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MCM2 SH2D2A PTPN7 RASAL3 SYTL3 NUP210 KIF22	1.39e-05	191	182	7	89eb4e30052d0d4a2952157ca743291900ce8de2
ToppCell	facs-Trachea-nan-3m-Lymphocytic-T_cell\|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MCM2 SH2D2A PTPN7 RASAL3 SYTL3 NUP210 KIF22	1.39e-05	191	182	7	0bf575eba311745fb75f9523f7fc81f73848e25d
ToppCell	COVID-19-lung-CD4+_Treg\|COVID-19 / Disease (COVID-19 only), tissue and cell type	DOCK10 INPP4B PTPN7 RASAL3 SYTL3 NUP210 GRAP2	1.39e-05	191	182	7	5a4ad5ae5c2dbfb225158cb598ef649c26a48350
ToppCell	facs-Trachea-nan-3m-Lymphocytic-nan\|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MCM2 SH2D2A PTPN7 RASAL3 SYTL3 NUP210 KIF22	1.39e-05	191	182	7	c57df363e3a6e61d2bdca1955330f1899b964267
ToppCell	COVID-19-T_cells\|COVID-19 / group, cell type (main and fine annotations)	DOCK10 SH2D2A INPP4B RASAL3 SYTL3 NUP210 GRAP2	1.39e-05	191	182	7	7f64add931b64b8d35836fa6bee9ebab593844d3
ToppCell	COVID-19-lung-CD4+_Treg\|lung / Disease (COVID-19 only), tissue and cell type	DOCK10 INPP4B PTPN7 RASAL3 SYTL3 NUP210 GRAP2	1.39e-05	191	182	7	73ea3078c1f55cd47e4d99e77b3ce4ff17549d49
ToppCell	critical-Lymphoid-CTL\|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	DOCK10 GIMAP1 SH2D2A PTPN7 RASAL3 SYTL3 GRAP2	1.44e-05	192	182	7	8c83050c1578d43ca0398ff920f30ea63f092a83
ToppCell	NS-critical-d_07-13-Lymphoid-CTL\|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	DOCK10 GIMAP1 SH2D2A PTPN7 RASAL3 SYTL3 GRAP2	1.44e-05	192	182	7	e7e5ba94ee8fd3c04bb4c358c86d0227c563e9dc
ToppCell	COVID-19-lung-CD8+_T_cells\|lung / Disease (COVID-19 only), tissue and cell type	DOCK10 SH2D2A INPP4B RASAL3 SYTL3 NUP210 GRAP2	1.49e-05	193	182	7	780e23e2705fc5c1b70e37568b79731ced5038bd
ToppCell	3'-Distal_airway-Immune_Lymphocytic-Lymphocytic_T/NK-CD4-positive,_alpha-beta_T_cell-CD4_T_cells\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DOCK10 GIMAP1 SH2D2A PTPN7 RASAL3 SYTL3 GRAP2	1.49e-05	193	182	7	7022b3ce6220d6d1722a4e2947630a8da002cdce
ToppCell	3'-Distal_airway-Immune_Lymphocytic-Lymphocytic_T/NK-CD4-positive,_alpha-beta_T_cell-CD4_T_cells-CD4_T_cells_L.1.1.1.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DOCK10 GIMAP1 SH2D2A PTPN7 RASAL3 SYTL3 GRAP2	1.49e-05	193	182	7	3083305b7ae09a37d7f45b915d49b2b396276822
ToppCell	3'-Distal_airway-Immune_Lymphocytic-Lymphocytic_T/NK-CD4-positive,_alpha-beta_T_cell\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DOCK10 GIMAP1 SH2D2A PTPN7 RASAL3 SYTL3 GRAP2	1.49e-05	193	182	7	1218e74ee5e00d230222b10acc50cb96201016b4
ToppCell	COVID-19-kidney-T-cells-1\|COVID-19 / Disease (COVID-19 only), tissue and cell type	DOCK10 SH2D2A INPP4B PTPN7 SYTL3 NUP210 GRAP2	1.49e-05	193	182	7	5b84fa640cf30dea55fde53b810f850ff946d253
ToppCell	10x_3'_v2v3-Non-neoplastic-Lymphoid-CD4/CD8-CD8_NK_sig-C\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	CTC1 F8 PTPN7 GTF3C1 SYTL3 PDP2 TRMT12	1.54e-05	194	182	7	6be74e4ba631b0c46cef2c580553f4c1ed29579e
ToppCell	3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_T/NK-CD4-positive,_alpha-beta_T_cell-CD4_T_cells\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	RNF213 SH2D2A INPP4B PTPN7 SYTL3 NUP210 GRAP2	1.54e-05	194	182	7	906fe1689906d1498acf6fd26a215c7e5a854a38
ToppCell	3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_T/NK-CD4-positive,_alpha-beta_T_cell-CD4_T_cells-CD4_T_cells_L.1.1.1.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	RNF213 SH2D2A INPP4B PTPN7 SYTL3 NUP210 GRAP2	1.54e-05	194	182	7	af7428582b96a500f255c45efc02b6c10c4740d9
ToppCell	COVID-19-lung-NK_cells\|COVID-19 / Disease (COVID-19 only), tissue and cell type	DOCK10 SH2D2A PTPN7 RASAL3 SYTL3 NUP210 GRAP2	1.54e-05	194	182	7	4c92f18e0a34fb50630d4b260eaf179202508b6d
ToppCell	3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_T/NK-CD4-positive,_alpha-beta_T_cell\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	RNF213 SH2D2A INPP4B PTPN7 SYTL3 NUP210 GRAP2	1.54e-05	194	182	7	4138f3e8aa214504fca03962a43250670ae45215
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_T/NK-T_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	DOCK10 SH2D2A INPP4B PTPN7 RASAL3 SYTL3 GRAP2	1.54e-05	194	182	7	633fe72cc8a489abde12428e326478409ca03263
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_T/NK-T_Cell-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	DOCK10 SH2D2A INPP4B PTPN7 RASAL3 SYTL3 GRAP2	1.54e-05	194	182	7	87a86df0b542f287b0b20f4a4b1a37002271671d
ToppCell	COVID-19-lung-NK_cells\|lung / Disease (COVID-19 only), tissue and cell type	DOCK10 SH2D2A PTPN7 RASAL3 SYTL3 NUP210 GRAP2	1.59e-05	195	182	7	3b716ec7acc9a37af6bf40e711a539ce58d74aa4
ToppCell	medial-Hematologic-Natural_Killer_T\|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	SH2D2A PTPN7 LRFN2 RASAL3 SYTL3 GRAP2 PVRIG	1.64e-05	196	182	7	6d8430ea37bb5ade25ae6b2b1a05158e72705e66
ToppCell	medial-Hematologic-Natural_Killer_T-2\|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	SH2D2A PTPN7 LRFN2 RASAL3 SYTL3 GRAP2 PVRIG	1.64e-05	196	182	7	510a2359947fc6658515b363f975329697692848
ToppCell	medial-2-Hematologic-Natural_Killer_T\|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	SH2D2A PTPN7 LRFN2 RASAL3 SYTL3 GRAP2 PVRIG	1.64e-05	196	182	7	c0a3749b06c47574ab252e96688aec9eea2924de
ToppCell	10x_3'_v2v3-Non-neoplastic-Lymphoid-CD4/CD8-Stress_sig-Z\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	RNF213 GIMAP1 SH2D2A INPP4B PTPN7 RASAL3 GRAP2	1.64e-05	196	182	7	578afe58962a24874b99b0407a647b12e972344b
ToppCell	Frontal_cortex-Endothelial-ENDOTHELIAL_STALK-Flt1_2\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	GIMAP1 DIPK2B TRIB3 USHBP1 DNAH6 PKN3	1.66e-05	131	182	6	d5bc40cd585582856881081b7130dec3515b4ae0
ToppCell	Bronchial-NucSeq-Immune_Myeloid-Mast_cell-Mast_cell\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CDK15 DOCK10 PARVB ADAM12 SYTL3 GRAP2 PDE7B	1.70e-05	197	182	7	bed8a9b73af5caee51b1232b31c24a59353658df
ToppCell	COVID-19-kidney-T-cells-1\|kidney / Disease (COVID-19 only), tissue and cell type	DOCK10 SH2D2A INPP4B PTPN7 RASAL3 SYTL3 GRAP2	1.70e-05	197	182	7	9bb7faf4ef63cca4d06c60e6c05a9616fdb6b98e
ToppCell	Bronchial-NucSeq-Immune_Myeloid-Mast_cell\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CDK15 DOCK10 PARVB ADAM12 SYTL3 GRAP2 PDE7B	1.70e-05	197	182	7	b7d5073d44aa1e2cb83ea8d8104c5ed662665755
ToppCell	metastatic_Lymph_Node-T/NK_cells\|metastatic_Lymph_Node / Location, Cell class and cell subclass	GIMAP1 SH2D2A INPP4B PTPN7 RASAL3 SYTL3 GRAP2	1.75e-05	198	182	7	d62884fc2697f7ad1b0227d29fb9345a18ea3429
ToppCell	T_cells\|World / Immune cells in Kidney/Urine in Lupus Nephritis	GIMAP1 SH2D2A INPP4B PTPN7 RASAL3 SYTL3 GRAP2	1.75e-05	198	182	7	1ca6cd8e75891fdfaddbb4a7342eec9ca4d11e5d
ToppCell	Tracheal-NucSeq-Immune_Myeloid-Mast_cell-Mast_cell\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CDK15 DOCK10 PARVB ADAM12 SYTL3 GRAP2 PDE7B	1.75e-05	198	182	7	cc5ca64749e2f4f1d373d9472824df85741702b7
ToppCell	10x5'v1-week_14-16-Mesenchymal_myocytic\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	MXRA5 MXRA8 ADAM12 TSKU CYP26C1 PDE7B CDH15	1.75e-05	198	182	7	55d2ed345101bec4b73f1242ba8c4d73073b7e88
ToppCell	background-Hepatic_Stellate_cells\|World / Sample and Cell Type and Tumor Cluster (all cells)	MXRA5 MXRA8 EMILIN1 INPP4B HHIP FNDC1 PODN	1.75e-05	198	182	7	79f32f965aed6a10c5cb803173e3db7b32e07a91
ToppCell	Tracheal-NucSeq-Immune_Myeloid-Mast_cell\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CDK15 DOCK10 PARVB ADAM12 SYTL3 GRAP2 PDE7B	1.75e-05	198	182	7	d4d66f19df078bfc3a83d4664aaf9c7789bde1a5
ToppCell	Parenchymal-NucSeq-Immune_Lymphocytic-T-T_CD4-CD4_TRM/EMRA\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	DOCK10 SH2D2A INPP4B PTPN7 SYTL3 NUP210 GRAP2	1.75e-05	198	182	7	90863377ed36afc30bc1a068612ad1adc77af5a8
ToppCell	Biopsy_Other_PF-Immune-Mast_cells\|Biopsy_Other_PF / Sample group, Lineage and Cell type	CDK15 ADAM12 PTPN7 SYTL3 GRAP2 HLTF PDE7B	1.75e-05	198	182	7	9f015553598d4c6774b2f9759e8c0f0f93e51c67
ToppCell	T_cells\|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues	SH2D2A INPP4B PTPN7 RASAL3 SYTL3 NUP210 GRAP2	1.75e-05	198	182	7	8372ceed063acad0e219644ddd58abbd1354e734
ToppCell	10x5'v1-week_14-16-Mesenchymal_osteo-stroma-osteoblast_precursor\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	MXRA5 MXRA8 ADAM12 EMILIN1 TSKU FNDC1 CDH15	1.75e-05	198	182	7	bc9c9f2c87282b5ef8514773e065d2a6b5dde338
ToppCell	background-Hepatic_Stellate_cells\|background / Sample and Cell Type and Tumor Cluster (all cells)	MXRA5 MXRA8 EMILIN1 INPP4B HHIP PODN EGFLAM	1.75e-05	198	182	7	bd11b0e9e80449aab979a02c1023e0638c431c7c
ToppCell	10x5'v1-week_14-16-Mesenchymal_myocytic-stroma\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	MXRA5 MXRA8 ADAM12 TSKU CYP26C1 PDE7B CDH15	1.75e-05	198	182	7	8602a518b5913625b1dd3cbc3c7e6efde0d5d942
ToppCell	Parenchymal-NucSeq-Immune_Lymphocytic-T-T_CD8-CD8\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	DOCK10 SH2D2A INPP4B PTPN7 RASAL3 SYTL3 GRAP2	1.81e-05	199	182	7	0d6463e368fd611a17327322413fad145f3c7f32
ToppCell	Sepsis-Leuk-UTI-Lymphocyte-T/NK-gd_T\|Leuk-UTI / Disease, condition lineage and cell class	ARHGEF19 PILRB PTPN7 RASAL3 GTF3C1 GRAP2 PODN	1.81e-05	199	182	7	b2c1b9ee764e1246bfa3ecf666ca76ae4ac6c362
ToppCell	Tracheal-10x5prime-Immune_Lymphocytic-T-T_CD8-CD8\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	DOCK10 GIMAP1 SH2D2A PTPN7 RASAL3 SYTL3 GRAP2	1.81e-05	199	182	7	c3aa72555fa3c2a0d85172682972d91fd9bb7b6a
Disease	polyp of colon	LAMA5 SIRT3 XRRA1 CDH15	3.30e-04	56	173	4	MONDO_0021400
Disease	catechol sulfate measurement	CHMP7 CARNS1	3.38e-04	5	173	2	EFO_0021151
Disease	telomere length	CDK15 CTC1 KCNB2 TERT ANKDD1A SCNN1D NINL CEP295	5.46e-04	313	173	8	EFO_0004505
Disease	Stage IV Skin Melanoma	ADAM12 ADAM33	7.04e-04	7	173	2	C1321872
Disease	Severe Congenital Microcephaly	PNKP WDR62 DNMT3A	7.89e-04	31	173	3	C3853041
Disease	serum alanine aminotransferase measurement, response to combination chemotherapy	HDAC4 RNF213 MCM2 CEP295	8.17e-04	71	173	4	EFO_0004735, EFO_0007965
Disease	level of Sphingomyelin (d40:1) in blood serum	NUP88 MTHFD2L GLTPD2	8.67e-04	32	173	3	OBA_2045182
Disease	X-17676 measurement	DNAH3 ALDH4A1	9.35e-04	8	173	2	EFO_0800785
Disease	Microlissencephaly	PNKP WDR62 DNMT3A	9.50e-04	33	173	3	C1956147
Disease	uterine fibroid, Menorrhagia	TERT SIRT3	1.20e-03	9	173	2	EFO_0000731, HP_0000132
Disease	propionylcarnitine measurement	CARNS1 PCCA	1.20e-03	9	173	2	EFO_0020942
Disease	platelet crit	DNAH3 DOCK10 LAMA5 SH2D2A TERT HDAC7 AK3 NUP205 PTPN7 ANKDD1A POLR1B PKN2 PKN3 CDH15	1.52e-03	952	173	14	EFO_0007985
Disease	guanosine diphosphate measurement	KCNB2 NINL	1.82e-03	11	173	2	EFO_0010494
Disease	gastric carcinoma	PGBD1 TERT LRFN2 PRKAA1	1.89e-03	89	173	4	EFO_0000178
Disease	sexual dimorphism measurement	HAGHL ACY3 FRS3 PGBD1 PEX1 KCNB2 LRRC43 PARP10 HHIP MFGE8 CMIP BTN1A1 CARNS1 DNMT3A ANKS1A	2.27e-03	1106	173	15	EFO_0021796
Disease	beta-hydroxyisovalerate measurement	MCCC1 PLEKHG5	2.97e-03	14	173	2	EFO_0800125
Disease	mitochondrial DNA measurement	DUS3L TERT AK3 NUP205 USHBP1 PTPRS VARS1	3.33e-03	328	173	7	EFO_0006312
Disease	lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma	MXRA8 TERT USHBP1	3.55e-03	52	173	3	EFO_0000305, EFO_0000571, EFO_0000708, EFO_0001071, EFO_0001075, EFO_0001663, EFO_1000650, EFO_1001515, EFO_1001516, MONDO_0005575
Disease	immature platelet count	DOCK10 TERT AK3 ANKDD1A	3.56e-03	106	173	4	EFO_0803544
Disease	myeloid white cell count	TERT HDAC7 AK3 CMIP GTF3C1 SUPV3L1 MTHFD2L POLR1B ADAM33 PKN2 PKN3 HTT DNMT3A	3.65e-03	937	173	13	EFO_0007988
Disease	Dyskeratosis Congenita	CTC1 TERT	3.89e-03	16	173	2	C0265965
Disease	Acute myeloid leukemia	TERT DNMT3A	4.39e-03	17	173	2	cv:C0023467
Disease	LEUKEMIA, ACUTE MYELOID	TERT DNMT3A	4.39e-03	17	173	2	601626
Disease	Malignant neoplasm of breast	HDAC4 ACADM SMARCAL1 GNB1L GIMAP1 ADAM12 TERT HDAC7 INPP4B MFGE8 ABCB10 PRKAA1 ADAM33 DNMT3A	4.49e-03	1074	173	14	C0006142
Disease	Disorder of organic acid metabolism	MCCC1 PCCA	4.92e-03	18	173	2	cv:C1263739
Disease	platelet-derived growth factor BB measurement	DOCK10 TRIB3 FAM124B	5.56e-03	61	173	3	EFO_0008264
Disease	lymphocyte count	TCTN3 NUP88 DOCK10 MCCC1 HDAC7 SIRT3 INPP4B CMIP RASAL3 PSME4 ARHGAP31 SUPV3L1 POLR1B PKN2 VARS1 HTT DNMT3A	5.72e-03	1464	173	17	EFO_0004587

Protein segments in the cluster

Peptide	Gene	Start	Entry
GPAHVLLLEQLRWER	USHBP1	521	Q8N6Y0
VVATHRANLKPWDGR	nan	96	Q6ZR03
RAPRDWGALLLHKAQ	BEND5	56	Q7L4P6
LRHDGAVRWDAPAIT	CHRNA10	136	Q9GZZ6
LVHGRLWRQDGVLAV	ACOT8	286	O14734
LARVQVFGKWHSVPR	ALKBH2	96	Q6NS38
FISRELRGQHLPAWI	ESYT3	96	A0FGR9
ALPSHGRVQWRGSLD	EP400	1776	Q96L91
SEDPLTLGNWHELRV	EGFLAM	686	Q63HQ2
ARHWLHAPAELQRAS	ACY3	31	Q96HD9
APALPSHVRWQGRRL	C8orf82	186	Q6P1X6
PAQLVWHRALRPGTA	CTC1	266	Q2NKJ3
QRLLGRSWSVPVIRH	DNMT3A	886	Q9Y6K1
RLSPNASAEHLELRW	BTN1A1	51	Q13410
WAVFRLAHPGVITRI	ALLC	261	Q8N6M5
ALGAVNWTPLHLAAR	ANKK1	621	Q8NFD2
RALLNHGAVRVWPGA	ASB10	351	Q8WXI3
EGWVHANRPKRLLLV	GPR32	246	O75388
LRRWEPHHLTLADNS	CMIP	81	Q8IY22
AWRLHPRAELGAVVD	CARNS1	176	A5YM72
ISLDGHDIRQLNPVW	ABCB10	551	Q9NRK6
WPQIKGRLLEEHSRI	ALDH4A1	361	P30038
HALARTPGQWETGLR	ADAM12	871	O43184
RRGLWAQRPHDSAQL	ADAM33	286	Q9BZ11
PLHLAAWKGDAQIVR	ANKS1A	116	Q92625
LAHRLLPELRDWGVA	DUS3L	446	Q96G46
PLIRRAWELGLMNTH	ACADM	76	P11310
LDLSHNALQRLRPGW	AMIGO3	66	Q86WK7
DWLVQNDPSLLHRVG	CEP170B	316	Q9Y4F5
EIRSDNWLASHLGLP	DIPK2B	76	Q9H7Y0
WLAHNEVRTVEPGAL	ISLR2	81	Q6UXK2
LSVWVHEAKGLPRAA	RASAL3	306	Q86YV0
VEGWKALHELNPRAA	C9orf64	46	Q5T6V5
KTALWHRLQGRPFVE	RABL6	56	Q3YEC7
HWDHARGNPELARLR	HAGHL	56	Q6PII5
RTAGHPLTRWALQRQ	PTPN7	76	P35236
LLAHLAERENIWGPF	INO80	556	Q9ULG1
NALWRRQPEAVHLLD	NUP205	26	Q92621
QRHPVSREWTLEAGA	MCM2	561	P49736
WAHDLPGLFEQRRLQ	MAP4K2	551	Q12851
RWLVRHGELVELAPL	ARHGEF19	591	Q8IW93
VFHRVRWAPELGASL	CYP27B1	11	O15528
APTQHLVLNLLDAWR	PAXIP1	801	Q6ZW49
TVHPGDRWVLETGRL	NUP210	351	Q8TEM1
GRSDPIQLEIHRGWL	FCGR1BP	91	Q92637
ALGPRAWVDLAHLQL	PODN	491	Q7Z5L7
NGLNSPIKRHRLASW	nan	16	O00370
NRGHVNWEILAPIRA	PRAMEF17	421	Q5VTA0
IRPDRKILATAGWDH	GNB1L	261	Q9BYB4
NLDWLRAKLDPLRGH	GPN2	91	Q9H9Y4
PEHAGRIQSIWSRLQ	HDAC4	676	P56524
HWLLDPHDGRRLAVR	LRP10	221	Q7Z4F1
ERLTIEGVLDHPWLN	MAPKAPK5	291	Q8IW41
HPWLVRQTARLAFLA	GLTPD2	226	A6NH11
WQRNPALKLAARLAH	NCDN	276	Q9UBB6
LGLQHWVPELARLNR	MFGE8	96	Q08431
PVAWHNRIALRLELL	MFGE8	371	Q08431
LGELSPHWDNLRKNV	INPP4B	286	O15327
IKQRLTARWIHPASG	AK3	121	Q9UIJ7
EAHARQLLLEEWGPL	NCCRP1	66	Q6ZVX7
PLDREARAWHNLTVL	CDH24	436	Q86UP0
VLWLDVHNFPGTSRR	KPTN	201	Q9Y664
ARLLAAHDVPVFGWR	OGDHL	16	Q9ULD0
WELQISPELLAHGRQ	KIF22	576	Q14807
RDHPRWGASNTALAR	TPO	161	P07202
AQWKSLLPRQHRSRG	PDE7B	411	Q9NP56
ESRILKWHQQRDPGS	KRT23	101	Q9C075
LPESARWIQRTHGKN	F8	1121	P00451
LSHLPDQRVALWRAA	MSLNL	146	Q96KJ4
LEFVGILARHRNWPS	LAMA5	3351	O15230
RPSVLCDGQWHRLAV	LAMA5	3596	O15230
PLRHKQADIRINGWA	PCCA	381	P05165
MIRRSLEQHGLPWAI	PRADC1	151	Q9BSG0
APQIGAWRNRLHFLE	HIPK3	106	Q9H422
EATLGIQLHWRPDIA	PKD1L2	1191	Q7Z442
AIRVLWRSPAPGRQH	PTPRS	736	Q13332
TVLEAVHDLLRPRGW	PARVB	151	Q9HBI1
RQHAGLLPESLIWAY	PAN3	606	Q58A45
WHKTDLAQRPANLGL	PDP2	436	Q9P2J9
PVLTWMELDNHGRRL	ARHGAP33	161	O14559
IDLRNPTLKARHWAA	DNAH6	961	Q9C0G6
LLHRRWSEAVAEVGP	GIMAP1	291	Q8WWP7
RLFRVLDSLQHSPWQ	FAM124B	81	Q9H5Z6
ALWRFAELAHLVRPQ	HTT	186	P42858
VGGLNHEVLWRTLDR	KCNB2	41	Q92953
WIHTLNRILQISPEG	DOCK10	281	Q96BY6
SLHVVWNRLGRVPEA	CDK15	346	Q96Q40
LSHTLGDPIKIRAWQ	DNAH3	3041	Q8TD57
HLLDELSRAQAWSGP	C21orf58	151	P58505
AWVALRRRHPGLAVE	FBXL8	241	Q96CD0
WAPLVLSHSRRQGVV	CHMP7	56	Q8WUX9
EGWVHANRPKRLLLV	GPR32P1	246	Q8NGA4
EPGWNGLAHRRAALL	FRS3	306	O43559
WEDLRRSPQRGASLH	FNDC1	906	Q4ZHG4
PLWAASAAGHLDVVR	FEM1A	86	Q9BSK4
LVTRNWRGQSHRLPA	CEACAM19	181	Q7Z692
LLGEHRLVRSQWPQS	CYP26C1	106	Q6V0L0
RLVRSQWPQSAHILL	CYP26C1	111	Q6V0L0
PHRGIKQVRTHWLLE	IDUA	81	P35475
LVAAERNRWHRLPSL	MCCC1	11	Q96RQ3
GRSDPIQLEIHRGWL	FCGR1A	91	P12314
RVTVVGPHRARQWLL	KHDC1	141	Q4VXA5
LEHLAVRQSPAWRIL	KNDC1	1591	Q76NI1
PWSLLQHIDERDRAG	GDF9	46	O60383
SHWLPAARGRLEQLG	EMILIN1	436	Q9Y6C2
WLRVILDEGHAIRNP	HLTF	551	Q14527
RHYRAPEVILALGWS	CLK4	341	Q9HAZ1
QRHEEPWRTGKLLLT	ESRRB	381	O95718
HPEHAGRIQSIWSRL	HDAC7	541	Q8WUI4
AGPAAQEWLSRDLLH	C1orf127	241	Q8N9H9
HTDPVQLQAAGRVRW	GRAP2	261	O75791
LLLHQSEWEGRISPE	CEP295	1376	Q9C0D2
HERSWPQGLATLETR	RNF41	251	Q9H4P4
TIQTRELPSGRWALH	SDK2	1436	Q58EX2
QLGLLFERHWHRPVL	SCNN1D	266	P51172
RWDHQAREGLSPGAL	CDH15	791	P55291
LRSVNLHKPRDLGWD	PEX1	826	O43933
VNRLPSWERGHLLAG	PROCA1	31	Q8NCQ7
PAWNRTGHLLIQGRD	C18orf63	116	Q68DL7
WAPLAQHERGSLASL	CTNND1	336	O60716
AQTPEHWVLRGVALL	DNAH5	4606	Q8TE73
EWHGRPKAVREQLLA	IRF2BP1	221	Q8IU81
GLVRSRHSPWALLNN	LRRC43	86	Q8N309
PLHEAAKRGNLSWLR	OSTF1	76	Q92882
AARHLVALLAGPWDQ	PARP10	781	Q53GL7
RPWAEQLRARHLEAL	PKN3	96	Q6P5Z2
LAPDHWERYTQLLRG	MR1	76	Q95460
TWLPNHVVFLRLREG	NUP88	16	Q99567
LGQLGALWIHNLRSR	MRPL22	6	Q9NWU5
SVVLGIRWLRVHAPE	RTL1	501	A6NKG5
SLNNDRLTVLLPGHW	RTL1	956	A6NKG5
LFLGPGRWQRNALHS	RTL1	1166	A6NKG5
VWHLGTLARRVFLGE	SYTL3	396	Q4VX76
GDLRILPEAHQRTWH	VARS1	696	P26640
PLNDHWTLRDGAALL	TAF6L	256	Q9Y6J9
HDIQRWLQGLRPLTE	RGL2	486	O15211
WLQGLRPLTEAQSHR	RGL2	491	O15211
HAGPIVSVWHRELRK	RPRD1B	36	Q9NQG5
RLHDERGQNPKTWAL	TEX14	116	Q8IWB6
AWRHTLPHNLSRQVL	SH2D2A	361	Q9NP31
LEELGRWGSAPRTHQ	SLC26A6	41	Q9BXS9
RHDILTGNWRVRSSP	PNLDC1	131	Q8NA58
QGSALMLHWRLPREL	EPHB6	381	O15197
HREWISKDPSRLVGQ	KIR3DS1	156	Q14943
WNPGVLIQAEDRVHR	SMARCAL1	806	Q9NZC9
WPIERLALTARVHGG	SHKBP1	236	Q8TBC3
LAWHPRSRDVAQLGD	SIRT3	351	Q9NTG7
LWHISRVDFLLQVPG	SLC26A10	401	Q8NG04
ELEHPAAWLLREAGQ	CCT8L2	81	Q96SF2
VNGLHPLTLRWEETR	PNKP	96	Q96T60
ALLWARLPAGRQAGH	SUPV3L1	6	Q8IYB8
LNTLKDRHPGDLWAR	PGBD1	311	Q96JS3
TWGRLVRRAIPTVNH	PKN2	516	Q16513
ELEGLWARLPKNRHS	NINL	571	Q9Y2I6
NQERWAIGPHDHILR	HHIP	306	Q96QV1
WLGAQRPDTLLTHVR	URB1	2226	O60287
LRQAWAQKHRGPATL	STRA8	196	Q7Z7C7
KWHLGIRSQSRPNDI	PRKAA1	406	Q13131
AWETDGLLPLERQLH	ANKDD1A	6	Q495B1
NGKWVEADPHLRLIR	CHST5	251	Q9GZS9
DALLTQGVHPRRWKL	PRAMEF6	86	Q5VXH4
RHTLWKRVQGAVTPL	RNF213	3621	Q63HN8
NIPEIAQLHRRLWAS	PLEKHG5	386	O94827
SALIQHWRVHTGERP	ZNF132	416	P52740
PRSQGHWSNADILRL	UBTFL6	11	P0CB48
AKWPDRITLLRGNHE	PPP6C	101	O00743
LGPALEWAVSHRQRL	RMND5B	171	Q96G75
RSHLWEAAQVVPDGL	TRIB3	326	Q96RU7
DALLTQGVHPRRWKL	PRAMEF5	86	Q5TYX0
LAARNPAKVWTDLRH	NUP188	621	Q5SRE5
HARNLALVWAPNLLR	ARHGAP31	166	Q2M1Z3
LAIVPNVRISWRRGH	PILRB	61	Q9UKJ0
GLAQQEWRVPELLHR	PSME4	1471	Q14997
VESWVSLGNRRPHLS	MTHFD2L	71	Q9H903
LVSWPALARHLQRVA	ZNF862	801	O60290
HGRWAERAGQEPLKT	WDR62	861	O43379
ERENPLAHLAAWGLV	USP41	41	Q3LFD5
LEADLPRSWQRHGNL	TRMT12	126	Q53H54
PRSWQRHGNLLLLSE	TRMT12	131	Q53H54
KRLHALSQAPEAWRL	TMEM129	81	A0AVI4
AEGWALPITHTRKQL	TRAPPC10	511	P48553
RHGQKGILSRLWPAE	POLR1B	886	Q9H9Y6
DPAQKGGWTRILNRH	TCTN3	466	Q6NUS6
LRLGRVFPHEVNWNK	GTF3C1	2091	Q12789
AWQHRAPRGLGEALV	VSIG10L2	181	P0DP72
LAWNRLHAVPNLRDL	TSKU	191	Q8WUA8
TTLAVLHPERGIRQW	PVRIG	86	Q6DKI7
DDRHRWQRLPQLSAA	PSPN	136	O60542
APLGAVLHQWTERRL	XRRA1	706	Q6P2D8
RAWNHSVREAGVPLG	TERT	201	O14746
PALRWHLQAPNGLRS	nan	96	Q6ZQT7
GSLQALDTWRTHIPR	nan	36	Q96M85
DLPSRFLHWRQVLSQ	TRIM16L	191	Q309B1
LHGLPWDSVRRMVNL	LRFN2	161	Q9ULH4
PLIARHTQRLWVLEG	LRFN4	281	Q6PJG9
EAHLSWILPNRRIIN	MXRA5	606	Q9NR99
LHDRQRVLHWDLRGP	MXRA8	66	Q9BRK3
VGHQARLSWLQRKAP	MYRIP	466	Q8NFW9